2.45
price up icon2.08%   0.05
after-market 시간 외 거래: 2.41 -0.04 -1.63%
loading
전일 마감가:
$2.40
열려 있는:
$2.35
하루 거래량:
502.86K
Relative Volume:
2.46
시가총액:
$42.21M
수익:
-
순이익/손실:
$-30.15M
주가수익비율:
-0.6125
EPS:
-4
순현금흐름:
$-21.66M
1주 성능:
+20.10%
1개월 성능:
+26.94%
6개월 성능:
+105.88%
1년 성능:
-30.40%
1일 변동 폭
Value
$2.30
$2.54
1주일 범위
Value
$2.0151
$2.54
52주 변동 폭
Value
$1.10
$6.01

Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile

Name
명칭
Nrx Pharmaceuticals Inc
Name
전화
484-254-6134
Name
주소
1201 ORANGE STREET, WILMINGTON
Name
직원
0
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
NRXP's Discussions on Twitter

NRXP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
NRXP
Nrx Pharmaceuticals Inc
2.45 35.14M 0 -30.15M -21.66M -4.00
Biotechnology icon
ONC
Beigene Ltd Adr
228.38 25.07B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.65 109.14B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.27 36.39M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
594.32 56.98B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
71.31 5.39B 0 -153.72M -103.81M -2.00

Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-02 개시 BTIG Research Buy

Nrx Pharmaceuticals Inc 주식(NRXP)의 최신 뉴스

pulisher
11:41 AM

NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress on Ketamine NDA and HOPE Clinic Rollup - The Globe and Mail

11:41 AM
pulisher
10:30 AM

NRx Pharmaceuticals (NASDAQ: NRXP) Set to Report Q1 Earnings in Wake of HOPE’s Strategic Kadima Agreement - financial-news.co.uk

10:30 AM
pulisher
04:35 AM

HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions - The Malaysian Reserve

04:35 AM
pulisher
01:37 AM

Earnings call transcript: NRx Pharmaceuticals targets profitability by end of 2025 in Q1 2025 - Investing.com Canada

01:37 AM
pulisher
12:27 PM

NRx Pharmaceuticals Reports Q1 2025 Results and Strategic Progress - TipRanks

12:27 PM
pulisher
May 15, 2025

Transcript : NRx Pharmaceuticals, Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

NRX Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025
pulisher
May 15, 2025

HOPE Therapeutics secures $7.8 million for clinic acquisitions By Investing.com - Investing.com South Africa

May 15, 2025
pulisher
May 15, 2025

$7.8 Million in New Financing for Clinic Acquisitions Supporting Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression and PTSD: NRXP - FinancialContent

May 15, 2025
pulisher
May 15, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics - Kilgore News Herald

May 15, 2025
pulisher
May 15, 2025

NRX Pharmaceuticals Reports First Quarter 2025 Financial Results And Provides Corporate Update - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

May 15, 2025
pulisher
May 15, 2025

IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Set to Report Q1 Earnings in Wake of HOPE's Strategic Kadima Agreement - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

HOPE Therapeutics secures $7.8 million for clinic acquisitions - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

NRX Pharmaceuticals Gets $7.8 Million Debt Financing From Universal Capital - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

HOPE Therapeutics Lands $7.8M Deal to Build National Mental Health Network with Ketamine Treatment Centers - Stock Titan

May 15, 2025
pulisher
May 15, 2025

HOPE Therapeutics and NRx Pharmaceuticals to buy Kadima Institute - MSN

May 15, 2025
pulisher
May 14, 2025

NRXP Expands with Acquisition of Kadima Neuropsychiatry Institut - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Plan Signed to Purchase Kadima Neuropsychiatry Institute as - openPR.com

May 13, 2025
pulisher
May 13, 2025

Plan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression and PTSD: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) | FinancialContent - FinancialContent

May 13, 2025
pulisher
May 13, 2025

IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry Institute - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

NRx Pharma, Hope in pact to buy Kadima (NRXP:NASDAQ) - Seeking Alpha

May 13, 2025
pulisher
May 13, 2025

HOPE Therapeutics to acquire Kadima Neuropsychiatry By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

HOPE Therapeutics To Buy Kadima Neuropsychiatry Institute For Undisclosed Sum - Nasdaq

May 13, 2025
pulisher
May 13, 2025

HOPE Therapeutics to acquire Kadima Neuropsychiatry - Investing.com

May 13, 2025
pulisher
May 13, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of In - StreetInsider

May 13, 2025
pulisher
May 12, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) to Report Q1 2025 Results on May 15 - The Globe and Mail

May 12, 2025
pulisher
May 12, 2025

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025 - BioSpace

May 12, 2025
pulisher
May 11, 2025

Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - MSN

May 11, 2025
pulisher
May 09, 2025

Plan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression and PTSD: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com

May 09, 2025
pulisher
May 08, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025 - PR Newswire

May 08, 2025
pulisher
May 06, 2025

IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Files Patent for Preservative-Free Ketamine Formulation - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NR - GuruFocus

May 06, 2025
pulisher
May 05, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) Files Patent for Preservative-Free Ketamine Formulation - TipRanks

May 05, 2025
pulisher
May 05, 2025

NRXP Seeks Patent for Innovative Depression Treatment | NRXP Sto - GuruFocus

May 05, 2025
pulisher
May 05, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV Ketamine - GuruFocus

May 05, 2025
pulisher
May 05, 2025

NRx Pharmaceuticals seeks patent for preservative-free ketamine By Investing.com - Investing.com India

May 05, 2025
pulisher
May 05, 2025

NRx Pharmaceuticals seeks patent for preservative-free ketamine - Investing.com

May 05, 2025
pulisher
May 05, 2025

NRXP's Groundbreaking Ketamine Patent Could Secure 20-Year Market Exclusivity for Depression Treatment - Stock Titan

May 05, 2025
pulisher
May 01, 2025

FDA Filing Fee Waiver for New Drug Application of NRX-100 for Suicidal Depression - Psychiatric Times

May 01, 2025
pulisher
May 01, 2025

Potential Success With DBS: Reducing Stigma and Addressing Unmet Need - Psychiatric Times

May 01, 2025
pulisher
Apr 30, 2025

$4.3 Million Waiver Exemption Granted by FDA on New Drug - openPR.com

Apr 30, 2025
pulisher
Apr 30, 2025

$4.3 Million Waiver Exemption Granted by FDA on New Drug Application Fee for Promising Treatment Addressing Suicidal Depression and PTSD: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com

Apr 30, 2025
pulisher
Apr 30, 2025

Wheat Sees Some Bargain Buying at Month End - The Globe and Mail

Apr 30, 2025
pulisher
Apr 30, 2025

Neuroscience and Psychiatry: Mending the Schism - Psychiatric Times

Apr 30, 2025
pulisher
Apr 30, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of F - GuruFocus

Apr 30, 2025

Nrx Pharmaceuticals Inc (NRXP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.28
price down icon 1.54%
$30.93
price up icon 7.58%
$565.63
price up icon 0.69%
$3.99
price up icon 5.28%
$285.31
price up icon 0.67%
$71.31
price up icon 2.56%
자본화:     |  볼륨(24시간):